FGFR4 Gly388 Arg polymorphism and prostate cancer risk in Scottish men

Prostate Cancer and Prostatic Diseases

Volumn 13, Issue 1, 2010, Pages 94-96

  Ho, C K M ^a   Anwar, S ^a   Nanda, J ^a   Habib, F K ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

FGFR4; Prostate cancer risk; Scottish

Indexed keywords

ARGININE; FIBROBLAST GROWTH FACTOR 4; GLYCINE; FIBROBLAST GROWTH FACTOR RECEPTOR 4;

ADULT; AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CONTROLLED STUDY; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; PROSTATE TUMOR;

AGED; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4;

EID: 76949089699     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2009.49     Document Type: Article

References (11)

1. NHS Scotland Information Services Division. Cancer in Scotland. 2008.
2. Sahadevan K, Darby S, Leung HY, Mathers ME, Robson CN, Gnanapragasam VJ. Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer. J Pathol 2007; 213: 82-90.
3. Wilkie AO, Morriss-Kay GM, Jones EY, Heath JK. Functions of fibroblast growth factors and their receptors. Curr Biol 1995; 5: 500-507.
4. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005; 16: 139-149.
5. Wang J, Stockton DW, Ittmann M. The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression. Clin Cancer Res 2004; 10 (18 Part 1): 6169-6178.
6. Ma Z, Tsuchiya N, Yuasa T, Inoue T, Kumazawa T, Narita S et al. Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population. Int J Cancer 2008; 123: 2574-2579.
7. Binnie MC, Alexander FE, Heald C, Habib FK. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer. Prostate 2005; 63: 309-315.
8. Bange J, Prechtl D, Cheburkin Y, Specht K, Harbeck N, Schmitt M et al. Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer Res 2002; 62: 840-847.
9. Bland JM, Altman DG. Statistics notes. The odds ratio. BMJ 2000; 320: 1468.
10. da Costa Andrade VC, Parise Jr O, Hors CP, de Melo Martins PC, Silva AP, Garicochea B. The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma. Exp Mol Pathol 2007; 82: 53-57.
11. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000; 85: 60-67.